0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Michaela A. Dinan, PhD; Xiaojuan Mi, PhD; Shelby D. Reed, PhD; et al.
JAMA Oncol. Published online August 27, 2015. doi:10.1001/jamaoncol.2015.2722
Includes: Supplemental Content

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Elizabeth M. Swisher, MD
JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2699

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Oncol. Published online August 13, 2015. doi:10.1001/jamaoncol.2015.2690
Includes: Supplemental Content

JAMA Oncology | 
Viewpoint |  FREE
Vered Stearns, MD; Ben Ho Park, MD, PhD
JAMA Oncol. 2015;1(5):569-570. doi:10.1001/jamaoncol.2015.0761.

JAMA Ophthalmology | 
Observation | 
Adam P. DeLuca, PhD; Matthew C. Weed, MD; Christine M. Haas; et al.
JAMA Ophthalmol. 2015;133(8):967-968. doi:10.1001/jamaophthalmol.2015.1463.

JAMA Pediatrics | 
Review | 
Hilary J. Vernon, MD, PhD
JAMA Pediatr. 2015;169(8):778-782. doi:10.1001/jamapediatrics.2015.0754.

JAMA | 
Viewpoint |  ONLINE FIRST
Steven J. Katz, MD, MPH; Allison W. Kurian, MD, MSc; Monica Morrow, MD
JAMA. Published online July 23, 2015. doi:10.1001/jama.2015.8088

JAMA Oncology | 
Viewpoint |  ONLINE FIRST
Laura E. MacConaill, PhD; Neal I. Lindeman, MD; Barrett J. Rollins, MD, PhD
JAMA Oncol. Published online July 16, 2015. doi:10.1001/jamaoncol.2015.1540

JAMA | 
Editorial | 
Roberto Romero, MD, DMedSci; Maurice J. Mahoney, MD, JD
JAMA. 2015;314(2):131-133. doi:10.1001/jama.2015.7523.

JAMA | 
Preliminary Communication | 
Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; et al.
JAMA. 2015;314(2):162-169. doi:10.1001/jama.2015.7120.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009
Michaela A. Dinan, PhD; Xiaojuan Mi, PhD; Shelby D. Reed, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Usefulness of Multigene Testing Catching the Train That’s Left the Station
Elizabeth M. Swisher, MD
JAMA Oncology
Original Investigation  | 
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond, BS; Allison W. Kurian, MD, MSc; Michele Gabree, MS, CGC; et al.
JAMA Ophthalmology
Observation  | 
Apparent Usher Syndrome Caused by the Combination of BBS1-Associated Retinitis Pigmentosa and SLC26A4-Associated Deafness
Adam P. DeLuca, PhD; Matthew C. Weed, MD; Christine M. Haas; et al.